Clinical Trial: Use of a novel topical
preparation of nitroglycerin in a double blind controlled
clinical trial in Raynaud's
This is a multi-center study with sites across the
country. Georgetown University is seeking to enroll
patients this week, as indicated below. If you do not
live in the Washington, D.C. area and are interested
in participating in this trial please visit www.clinicaltrials.gov/ct/show/NCT00266669?order=10
Patients must have at least two episodes of Raynaud's
daily, are NOT on any Raynaud's medicines (Procardia
or Norvasc). You must be available to come to Georgetown
THIS week (March 6) and then weekly for brief visits
for the next seven weeks. Patients would receive $400
plus parking if they complete the two-month study. You
also would receive the real drug for the following two
months.
We still have a few spots for this study. If anyone
wants to participate please contact Adrienne at 202-687-6317
or alm62@georgetown.edu.
Patients must be screened this week.
|
